Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Comput Math Methods Med ; 2021: 8591036, 2021.
Article in English | MEDLINE | ID: covidwho-1523094

ABSTRACT

During the ongoing COVID-19 pandemic, Internet of Things- (IoT-) based health monitoring systems are potentially immensely beneficial for COVID-19 patients. This study presents an IoT-based system that is a real-time health monitoring system utilizing the measured values of body temperature, pulse rate, and oxygen saturation of the patients, which are the most important measurements required for critical care. This system has a liquid crystal display (LCD) that shows the measured temperature, pulse rate, and oxygen saturation level and can be easily synchronized with a mobile application for instant access. The proposed IoT-based method uses an Arduino Uno-based system, and it was tested and verified for five human test subjects. The results obtained from the system were promising: the data acquired from the system are stored very quickly. The results obtained from the system were found to be accurate when compared to other commercially available devices. IoT-based tools may potentially be valuable during the COVID-19 pandemic for saving people's lives.


Subject(s)
COVID-19/physiopathology , Computer Systems , Internet of Things , Monitoring, Physiologic/instrumentation , Adult , Body Temperature , COVID-19/diagnosis , COVID-19/epidemiology , Computational Biology , Computer Systems/statistics & numerical data , Equipment Design , Female , Heart Rate , Humans , Male , Middle Aged , Mobile Applications , Monitoring, Physiologic/statistics & numerical data , Oxygen Saturation , Pandemics , SARS-CoV-2 , User-Computer Interface , Young Adult
2.
Open Heart ; 8(1)2021 06.
Article in English | MEDLINE | ID: covidwho-1259016

ABSTRACT

AIMS: In response to the COVID-19 pandemic, the UK was placed under strict lockdown measures on 23 March 2020. The aim of this study was to quantify the effects on physical activity (PA) levels using data from the prospective Triage-HF Plus Evaluation study. METHODS: This study represents a cohort of adult patients with implanted cardiac devices capable of measuring activity by embedded accelerometery via a remote monitoring platform. Activity data were available for the 4 weeks pre-implementation and post implementation of 'stay at home' lockdown measures in the form of 'minutes active per day' (min/day). RESULTS: Data were analysed for 311 patients (77.2% men, mean age 68.8, frailty 55.9%. 92.2% established heart failure (HF) diagnosis, of these 51.2% New York Heart Association II), with comorbidities representative of a real-world cohort.Post-lockdown, a significant reduction in median PA equating to 20.8 active min/day was seen. The reduction was uniform with a slightly more pronounced drop in PA for women, but no statistically significant difference with respect to age, body mass index, frailty or device type. Activity dropped in the immediate 2-week period post-lockdown, but steadily returned thereafter. Median activity week 4 weeks post-lockdown remained significantly lower than 4 weeks pre-lockdown (p≤0.001). CONCLUSIONS: In a population of predominantly HF patients with cardiac devices, activity reduced by approximately 20 min active per day in the immediate aftermath of strict COVID-19 lockdown measures. TRIAL REGISTRATION NUMBER: NCT04177199.


Subject(s)
Accelerometry , COVID-19 , Communicable Disease Control , Heart Failure , Monitoring, Physiologic , Physical Distancing , Telemedicine , Accelerometry/instrumentation , Accelerometry/methods , Accelerometry/statistics & numerical data , Activities of Daily Living , Aged , COVID-19/epidemiology , COVID-19/prevention & control , Communicable Disease Control/methods , Communicable Disease Control/statistics & numerical data , Exercise , Female , Heart Failure/diagnosis , Heart Failure/epidemiology , Humans , Male , Monitoring, Physiologic/instrumentation , Monitoring, Physiologic/methods , Monitoring, Physiologic/statistics & numerical data , SARS-CoV-2 , Telemedicine/instrumentation , Telemedicine/methods , Telemedicine/statistics & numerical data , United Kingdom/epidemiology , Wearable Electronic Devices
3.
Sci Rep ; 11(1): 11524, 2021 06 01.
Article in English | MEDLINE | ID: covidwho-1253988

ABSTRACT

Nearly 5% of patients suffering from COVID-19 develop acute respiratory distress syndrome (ARDS). Extravascular lung water index (EVLWI) is a marker of pulmonary oedema which is associated with mortality in ARDS. In this study, we evaluate whether EVLWI is higher in patients with COVID-19 associated ARDS as compared to COVID-19 negative, ventilated patients with ARDS and whether EVLWI has the potential to monitor disease progression. EVLWI and cardiac function were monitored by transpulmonary thermodilution in 25 patients with COVID-19 ARDS subsequent to intubation and compared to a control group of 49 non-COVID-19 ARDS patients. At intubation, EVLWI was noticeably elevated and significantly higher in COVID-19 patients than in the control group (17 (11-38) vs. 11 (6-26) mL/kg; p < 0.001). High pulmonary vascular permeability index values (2.9 (1.0-5.2) versus 1.9 (1.0-5.2); p = 0.003) suggested a non-cardiogenic pulmonary oedema. By contrast, the cardiac parameters SVI, GEF and GEDVI were comparable in both cohorts. High EVLWI values were associated with viral persistence, prolonged intensive care treatment and in-hospital mortality (23.2 ± 6.7% vs. 30.3 ± 6.0%, p = 0.025). Also, EVLWI showed a significant between-subjects (r = - 0.60; p = 0.001) and within-subjects correlation (r = - 0.27; p = 0.028) to Horowitz index. Compared to non COVID-19 ARDS, COVID-19 results in markedly elevated EVLWI-values in patients with ARDS. High EVLWI reflects a non-cardiogenic pulmonary oedema in COVID-19 ARDS and could serve as parameter to monitor ARDS progression on ICU.


Subject(s)
COVID-19/complications , Extravascular Lung Water/immunology , Pulmonary Edema/mortality , Respiratory Distress Syndrome/mortality , Adult , Aged , Aged, 80 and over , COVID-19/diagnosis , COVID-19/immunology , COVID-19/mortality , Capillary Permeability , Disease Progression , Extravascular Lung Water/virology , Female , Hospital Mortality , Humans , Intensive Care Units/statistics & numerical data , Length of Stay/statistics & numerical data , Lung/blood supply , Lung/physiopathology , Male , Middle Aged , Monitoring, Physiologic/methods , Monitoring, Physiologic/statistics & numerical data , Prognosis , Pulmonary Edema/diagnosis , Pulmonary Edema/immunology , Pulmonary Edema/virology , Respiration, Artificial , Respiratory Distress Syndrome/diagnosis , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/therapy , Risk Assessment/methods , SARS-CoV-2/isolation & purification , Severity of Illness Index , Thermodilution/methods , Thermodilution/statistics & numerical data , Young Adult
4.
Am J Med Qual ; 36(3): 139-144, 2021.
Article in English | MEDLINE | ID: covidwho-1214705

ABSTRACT

The coronavirus pandemic catalyzed a digital health transformation, placing renewed focus on using remote monitoring technologies to care for patients outside of hospitals. At NewYork-Presbyterian, the authors expanded remote monitoring infrastructure and developed a COVID-19 Hypoxia Monitoring program-a critical means through which discharged COVID-19 patients were followed and assessed, enabling the organization to maximize inpatient capacity at a time of acute bed shortage. The pandemic tested existing remote monitoring efforts, revealing numerous operating challenges including device management, centralized escalation protocols, and health equity concerns. The continuation of these programs required addressing these concerns while expanding monitoring efforts in ambulatory and transitions of care settings. Building on these experiences, this article offers insights and strategies for implementing remote monitoring programs at scale and improving the sustainability of these efforts. As virtual care becomes a patient expectation, the authors hope hospitals recognize the promise that remote monitoring holds in reenvisioning health care delivery.


Subject(s)
COVID-19/therapy , Continuity of Patient Care/organization & administration , Monitoring, Physiologic/statistics & numerical data , Telemedicine/organization & administration , Decision Support Systems, Clinical , Humans , Monitoring, Ambulatory/statistics & numerical data , New York City , Outcome Assessment, Health Care
5.
Math Biosci Eng ; 18(2): 1513-1528, 2021 01 28.
Article in English | MEDLINE | ID: covidwho-1150821

ABSTRACT

The internet of things (IoT) and deep learning are emerging technologies in diverse research fields, including the provision of IT services in medical domains. In the COVID-19 era, intelligent medication behavior monitoring systems for stable patient monitoring are further required, because many patients cannot easily visit hospitals. Several previous studies made use of wearable devices to detect medication behaviors of patients. However, the wearable devices cause inconvenience while equipping the devices. In addition, they suffer from inconsistency problems due to errors of measured values. We devise a medication behavior monitoring system that uses the IoT and deep learning to avoid sensing errors and improve user experiences by effectively detecting various activities of patients. Based on the real-time operation of our proposed IoT device, the proposed solution processes captured images of patents via OpenPose to check medication situations. The proposed system identifies medication status on time by using a human activity recognition scheme and provides various notifications to patients' mobile devices. To support reliable communication between our system and doctors, we employ MQTT protocol with periodic data transmissions. Thus, the measured information of patient's medication status is transmitted to the doctors so that they can periodically perform remote treatments. Experimental results show that all medication behaviors are accurately detected and notified to the doctor efficiently, improving the accuracy of monitoring the patient's medication behavior.


Subject(s)
COVID-19 Drug Treatment , Deep Learning , Medication Adherence , Monitoring, Physiologic/methods , SARS-CoV-2 , Biomedical Engineering , Computer Systems , Directly Observed Therapy , Equipment Design , Humans , Internet of Things , Medication Adherence/psychology , Medication Adherence/statistics & numerical data , Monitoring, Physiologic/instrumentation , Monitoring, Physiologic/statistics & numerical data , Neural Networks, Computer , Pandemics , Software , Wearable Electronic Devices
6.
PLoS One ; 15(11): e0240526, 2020.
Article in English | MEDLINE | ID: covidwho-1067387

ABSTRACT

In-person (face-to-face) data collection methods offer many advantages but can also be time-consuming and expensive, particularly in areas of difficult access. We take advantage of the increasing mobile phone penetration rate in rural areas to evaluate the feasibility of using cell phones to monitor the provision of key health and nutrition interventions linked to the first 1,000 days of life, a critical period of growth and development. We examine response rates to calendarized text messages (SMS) and phone calls sent to 1,542 households over a period of four months. These households have children under two years old and pregnant women and are located across randomly selected communities in Quiche, Guatemala. We find that the overall (valid) response rate to phone calls is over 5 times higher than to text messages (75.8% versus 14.4%). We also test whether simple SMS reminders improve the timely reception of health services but do not find any effects in this regard. Language, education, and age appear to be major barriers to respond to text messages as opposed to phone calls, and the rate of response is not correlated with a household's geographic location (accessibility). Moreover, response veracity is high, with an 84-91% match between household responses and administrative records. The costs per monitored intervention are around 1.12 US dollars using text messages and 85 cents making phone calls, with the costs per effective answer showing a starker contrast, at 7.76 and 1.12 US dollars, respectively. Our findings indicate that mobile phone calls can be an effective, low-cost tool to collect reliable information remotely and in real time. In the current context, where in-person contact with households is not possible due to the COVID-19 crisis, phone calls can be a valuable instrument for collecting information, monitoring development interventions, or implementing brief surveys.


Subject(s)
Cell Phone/statistics & numerical data , Coronavirus Infections/epidemiology , Monitoring, Physiologic/statistics & numerical data , Nutritional Status/physiology , Pandemics , Pneumonia, Viral/epidemiology , Rural Population/statistics & numerical data , Adult , COVID-19 , Cell Phone/economics , Child, Preschool , Female , Guatemala/epidemiology , Humans , Infant , Infant, Newborn , Male , Monitoring, Physiologic/economics , Pregnancy , Reminder Systems/economics , Reminder Systems/statistics & numerical data , Surveys and Questionnaires , Telemedicine/economics , Telemedicine/statistics & numerical data , Text Messaging/economics , Text Messaging/statistics & numerical data
8.
Int J Nurs Stud ; 115: 103868, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1002645

ABSTRACT

BACKGROUND: Continuous remote monitoring of vital signs on the hospital ward gained popularity during the Severe Acute Respiratory Syndrome coronavirus 2 pandemic due to its ability to support early detection of respiratory failure, and the possibility to do so without physical contact between patient and clinician. The effect of continuous monitoring on patient room visits has not been established yet. OBJECTIVES: To assess the impact of continuous monitoring on the number of patient room visits for patients suspected of Corona Virus Disease 2019 (COVID-19) and the use of personal protection equipment. DESIGN AND METHODS: We performed a before-after study at a ward with private rooms for patients suspected of COVID-19 at a tertiary hospital in Nijmegen, The Netherlands. Non-participant observers observed hospital staff during day, evening and night shifts to record patient room visits and personal protection equipment usage. After eleven days, wearable continuous vital sign monitoring was introduced. An interrupted time series analysis was applied to evaluate the effect of continuous monitoring on the number of patient room visits, visits for obtaining vital signs (Modified Early Warning Score visits) and the amount of personal protection equipment used. RESULTS: During the 45 day study period, 86 shifts were observed. During each shift, approximately six rooms were included. A total of 2347 patient room visits were recorded. The slope coefficient for the number of patient room visits did not change after introducing continuous vital sign monitoring (B -0.003, 95% confidence interval -0.022/0.016). The slope coefficients of the number of Modified Early Warning Score visits and the amount of personal protection equipment used did not change either (B -0.002, 95% confidence interval -0.021/0.017 and B 0.046, 95% confidence interval -0.008/0.099). The number of Modified Early Warning Score visits did show a decline over the entire study period, however this decline was not influenced by the intervention. Evening and night shifts were associated with fewer patient room visits compared to day shifts. CONCLUSION: Introduction of continuous vital sign monitoring at a general ward for patients with suspected COVID-19 did not reduce the number of patient room visits or the usage of personal protection equipment by hospital staff. The number of Modified Early Warning Score visits declined over time, but this was not related to the introduction of continuous monitoring. Detailed analysis of the influence of continuous monitoring on the workflow of hospital staff reveals key points to increase efficacy of this intervention.


Subject(s)
COVID-19/prevention & control , Monitoring, Physiologic/statistics & numerical data , Patients' Rooms/statistics & numerical data , Humans , Netherlands , Nursing Staff, Hospital/statistics & numerical data , Patient Isolation , Personal Protective Equipment/statistics & numerical data , SARS-CoV-2 , Vital Signs/physiology
9.
Resuscitation ; 158: 30-38, 2021 01.
Article in English | MEDLINE | ID: covidwho-933459

ABSTRACT

INTRODUCTION: Coronavirus disease 2019 (COVID-19) placed increased burdens on National Health Service hospitals and necessitated significant adjustments to their structures and processes. This research investigated if and how these changes affected the patterns of vital sign recording and staff compliance with expected monitoring schedules on general wards. METHODS: We compared the pattern of vital signs and early warning score (EWS) data collected from admissions to a single hospital during the initial phase of the COVID-19 pandemic with those in three control periods from 2018, 2019 and 2020. Main outcome measures were weekly and monthly hospital admissions; daily and hourly patterns of recorded vital signs and EWS values; time to next observation and; proportions of 'on time', 'late' and 'missed' vital signs observations sets. RESULTS: There were large falls in admissions at the beginning of the COVID-19 era. Admissions were older, more unwell on admission and throughout their stay, more often required supplementary oxygen, spent longer in hospital and had a higher in-hospital mortality compared to one or more of the control periods. More daily observation sets were performed during the COVID-19 era than in the control periods. However, there was no clear evidence that COVID-19 affected the pattern of vital signs collection across the 24-h period or the week. CONCLUSIONS: The increased burdens of the COVID-19 pandemic, and the alterations in healthcare structures and processes necessary to respond to it, did not adversely affect the hospitals' ability to monitor patients under its care and to comply with expected monitoring schedules.


Subject(s)
COVID-19 , Guideline Adherence/statistics & numerical data , Hospitalization , Monitoring, Physiologic/statistics & numerical data , Patients' Rooms/organization & administration , Vital Signs , Aged , Aged, 80 and over , Female , Hospitalization/statistics & numerical data , Humans , Male
10.
IEEE Pulse ; 11(5): 24-27, 2020.
Article in English | MEDLINE | ID: covidwho-873192

ABSTRACT

Citizens' dissatisfaction with the scope of the United States health care system has been a hot topic for many years. In a country where patient to nurse ratios remain 6:1, even universal health care coverage cannot guarantee adequate patient care. These issues were further highlighted by the COVID-19 pandemic, where inadequate hospital funding and lack of attention to patients led to challenging situations in hotspot areas. Although this pandemic will shape us for many years to come with far reaching impacts, social distancing norms have accelerated technologies that enable services to be delivered remotely, a capability even more necessary in our health care system. By providing care that can be delivered remotely, we can focus in-person care in our hospitals to only the ones who really need it. This allows us to scale our systems, protect lives, and safeguard economic activity.


Subject(s)
Delivery of Health Care , Internet of Things , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Cost Savings , Delivery of Health Care/economics , Equipment and Supplies , Humans , Monitoring, Physiologic/methods , Monitoring, Physiologic/statistics & numerical data , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , Remote Sensing Technology , SARS-CoV-2 , Transportation , United States/epidemiology , Waste Management
12.
Clin Chem Lab Med ; 58(9): 1441-1449, 2020 08 27.
Article in English | MEDLINE | ID: covidwho-605894

ABSTRACT

Objectives: The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force on COVID-19 conducted a global survey to understand how biochemistry laboratories manage the operational challenges during the coronavirus disease 2019 (COVID-19) pandemic. Materials and methods: An electronic survey was distributed globally to record the operational considerations to mitigate biosafety risks in the laboratory. Additionally, the laboratories were asked to indicate the operational challenges they faced. Results: A total of 1210 valid submissions were included in this analysis. Most of the survey participants worked in hospital laboratories. Around 15% of laboratories restricted certain tests on patients with clinically suspected or confirmed COVID-19 over biosafety concerns. Just over 10% of the laboratories had to restrict their test menu or services due to resource constraints. Approximately a third of laboratories performed temperature monitoring, while two thirds of laboratories increased the frequency of disinfection. Just less than 50% of the laboratories split their teams. The greatest reported challenge faced by laboratories during the COVID-19 pandemic is securing sufficient supplies of personal protective equipment (PPE), analytical equipment, including those used at the point of care, as well as reagents, consumables and other laboratory materials. This was followed by having inadequate staff, managing their morale, anxiety and deployment. Conclusions: The restriction of tests and services may have undesirable clinical consequences as clinicians are deprived of important information to deliver appropriate care to their patients. Staff rostering and biosafety concerns require longer-term solutions as they are crucial for the continued operation of the laboratory during what may well be a prolonged pandemic.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Laboratories, Hospital/organization & administration , Laboratories, Hospital/statistics & numerical data , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Surveys and Questionnaires , Body Temperature , COVID-19 , Containment of Biohazards/statistics & numerical data , Disease Outbreaks , Disinfection/statistics & numerical data , Health Workforce/organization & administration , Health Workforce/statistics & numerical data , Humans , Monitoring, Physiologic/statistics & numerical data , Personal Protective Equipment/statistics & numerical data , Risk Management/statistics & numerical data , SARS-CoV-2
14.
Artif Organs ; 44(8): 873-876, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-401294

ABSTRACT

Coronavirus disease 2019 (COVID-19) is a pandemic touching thousands of people all around the world. Patients supported with left ventricular assist devices (LVADs) are affected by long-standing cardiovascular diseases and subjected to variations of the normal cardiovascular physiology, thus requiring an even closer monitoring during the COVID-19 outbreak. Nevertheless, the COVID-19 pandemic led to a drastic reduction in routine clinical activities and a consequent risk of looser connections between LVAD patients and their referring center. Potential deleterious effects of such a situation can be a delayed recognition of LVAD-related complications, misdiagnosis of COVID-19, and impaired social and psychological well-being for patients and families. As one of the largest LVAD programs worldwide, we designed a sustainable and enforceable telemonitoring algorithm which can be easily adapted to every LVAD center so as to maintain optimal quality of care for LVAD patients during the COVID-19 pandemic.


Subject(s)
Coronavirus Infections/epidemiology , Heart Failure/therapy , Heart-Assist Devices/statistics & numerical data , Infection Control/organization & administration , Outcome Assessment, Health Care , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , Ambulatory Care/organization & administration , COVID-19 , Coronavirus Infections/prevention & control , Female , Global Health , Heart Failure/epidemiology , Humans , Male , Monitoring, Physiologic/methods , Monitoring, Physiologic/statistics & numerical data , Outpatients/statistics & numerical data , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Program Evaluation
SELECTION OF CITATIONS
SEARCH DETAIL